Establishment of a Brain and Spinal Tumor Tissue Bank and Clinical Data Repository for Identifying Molecular Markers of Clinical Outcome
Glioblastoma multiforme (GBM) is the most common and lethal primary Brain and Spinal Tumor
in adults. It is nearly uniformly fatal, with a median survival of approximately one year,
despite modern treatment modalities. Efforts to understand why some patients live longer or
shorter than the average may provide insights into the biology of these neoplasms. For
years, researchers have tried to identify independent predictors that could help in
treatment planning. With the recent interest in molecular biology and molecular genetics,
tumor markers are now being examined as potential predictors. A marker that could predict
tumor response to therapy, the likelihood of recurrence, and survival would thus be quite
useful.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Collect, annotate, and store fresh frozen specimens of normal tissue, tumors, and pre-malignant lesions for biological investigation.
5 years
No
Kuo-Sheng Hung, MD, PhD
Principal Investigator
Taipei Medical University-Wan Fang Hospital
Taiwan: Department of Health
2008WFCRC-01
NCT00686387
May 2008
May 2013
Name | Location |
---|